Login
Navigate Fool.com
Will EXAS beat
the market?

EXACT Sciences Corp

NASDAQ: EXAS

Community Rating: 2 Stars: Unattractive

12.84 0.40 (3.22%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.40
Previous Close $12.44
Daily Range $12.27 - $12.98
52-Week Range $6.93 - $15.60
Market Cap $914.2M
P/E Ratio -18.61
Dividend (Yield) $0.00 (0.0%)
Volume 2,661,313
Average Daily Volume 2,937,946
Current FY EPS -$0.77

How do you think EXAS
will perform against the market?

Top EXAS Bull/Bear Pitches

 

NHWeston (9.85)
Submitted June 1, 2011

Exact Sciences stakes its future on a pioneering and extremely promising gambit - replacing the colonoscopy with a highly-reliable, completely non-invasive test for rectal and intestinal cancer. Its t … More

0 Replies Reply Report this Post
 

zzlangerhans (< 20)
Submitted October 24, 2011

Exact's share price seems to be getting ahead of itself yet again as the Cologuard trial enters the early stages of an enrollment process that will likely extend at least another 12 months. That means … More

0 Replies Reply Report this Post

News & Commentary Rss Feed

Why Exact Sciences, Builders FirstSource, and Clayton Williams Energy Jumped Today

The stock market posted strong gains Monday, defying calls that the stock market is rigged. Find out more about what made these three stocks soar.

Noteworthy ETF Outflows: XBI, GERN, ACHN, EXAS

Monday's ETF Movers: FBT, GDXJ

EXACT Sciences (EXAS) Shares Cross Below 200 DMA

Friday's ETF Movers: GXC, FBT

Morning Movers in Biotech: Ariad Pharmaceuticals, Exact Sciences Corporation and MannKind Corp

Today's top stories in biotech and health care.

Morning Movers in Biotech: Clovis Oncology, Inc., Exact Sciences Corporation, GlaxoSmithKline PLC, a

Today's top stories in health care and biotech.

3 Biotechs Bucking the Downtrend

Three biotech winners amid a sea of losers.

Mid-Afternoon Market Update: Markets Recover Slightly As Healthcare Stocks Continue to Show Weakness

3 Upcoming FDA Meetings You Should be Watching

With three FDA panel meetings to close out the month investors should have their eyes on these three companies.

See More EXAS News...

Sector

Healthcare

Industry

Drugs

EXACT Sciences Corp (EXAS) Description

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer. Website: http://www.exactsciences.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks